Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Impact of Daratumumab-Containing Induction Therapy on Stem Cell Mobilization in Multiple Myeloma: A Retrospective, Single-Center Analysis

Hegta R. Figueiroa, Germano Medeiros, Juliana Matos Pessoa, Paula Lucafo Zenero, Isabella Pittol, Fauze Lutfe Ayoub, Pedro Paulo Faust Machado, Gabriela Camargo, Dimitra Oliveira Delijaicov, André Larubia, Arlett Edna Lazar, Jose Ulysses A. Filho, Breno Gusmao, Fabio R. Kerbauy, André Dias Americo, Phillip Scheinberg

Blood (2024) 144 (Supplement 1): 7262.

https://doi.org/10.1182/blood-2024-210191

Published: 2024

Journal Articles

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Blood (2024) 144 (Supplement 1): 6718.

https://doi.org/10.1182/blood-2024-209513

Published: 2024

Journal Articles

Autologous Stem Cell Transplantation (ASCT) for Light Chain (AL) Amyloidosis: A Single-Center Report

Natalia Pin Chuen Zing, Breno Gusmao, Juliana Matos Pessoa, Jose Ulysses A. Filho, Fabio R. Kerbauy, Hegta R. Figueiroa, Isabella Pittol, Paula Lucafo Zenero, Phillip Scheinberg, Germano Lima, André Américo, Fauze Lutfe Ayoub

Blood (2024) 144 (Supplement 1): 6900.

https://doi.org/10.1182/blood-2024-211920

Published: 2024

Journal Articles

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Blood (2024) 144 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2024-211584

Published: 2024

Journal Articles

Real World Evidence- the Proportion of Myeloma Patients' Death Due to Early Progression

Blood (2023) 142 (Supplement 1): 3789.

https://doi.org/10.1182/blood-2023-187790

Published: 2023

Journal Articles

Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Marcelo Iastrebner, Renee Leonor Crisp, Roberto Ovilla, Andres Gomez-De Leon, Adriana Karola Puente, Fernando Barroso Duarte, Elvira DRP Velloso, Breno Gusmao, Ana Varela, Matilde Boada, Sofia Grille

Blood (2022) 140 (Supplement 1): 12329–12330.

https://doi.org/10.1182/blood-2022-163174

Published: 2022

Journal Articles

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Roberto Ovilla, MD, Renee Leonor Crisp, PhD, Pamela E Baez-Islas, MD, Jorge A Arbelbide, MD, Sofia Grille, MD PhD, Lilián Díaz, MD, Henry Idrobo, MD Professor, Alicia Enrico, MD, Maria J Mela Osorio, MD, Isolda I. Fernandez, MD, Luciana C Ferrari, MD, Nidia Zapata, MD, Adrian A Ceballos-Lopez, Veronica Mena, MD, Ana L Romero, MD, Juan Carlos Serrano, MD, Gabriela Vidal-Senmache, MD, Fernando Barroso Duarte, MD, Edit N Pintos, MD, Mariana Rosenhain, MD, Laura Kornblihtt, MD, Natalia Tejeira, MD, Breno Gusmao, MD, Maria Elena Del Rocio Buenaño, MD, Marcos Di Stefano, MD, Matilde Boada, MD, Alberto Gimenez Conca, MD, Maria Perusini, MD, Hernan Dick, MD, Santiago Cranco, MD, Maria Lucia Fuente, Alicia Beatriz Navickas, MD, Maria M Moirano, MD, Natalia Oliveira, MD, Jacqueline Gonzalez, MD, Mariana Bandín, MD, Noelia Villaverde, MD, Alejandro Suero, MD, Juan Felipe Lasso, MD, Nora Carrara, MD, Xochitl Cota, MD, Carolina Lazzarino, MD, Maria Leticia Rapan, MD, Marcelo Iastrebner, MD, Latin-American MDS Group (GLAM), MDS and Acute Leukemia Sub-Commission Group Argentinian Society of Hematology

Blood (2019) 134 (Supplement_1): 5096.

https://doi.org/10.1182/blood-2019-125311

Published: 2019

Journal Articles

Analysis of Patterns of Co-Occurrence and Mutual Exclusivity of Gene Mutations in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Fabio P S Santos, MD, Raquel MA Paiva, PhD, Renato D Puga, MSc, Giulliana AR Goncalves, MSc, Tarcila Santos Datoguia, MD, Welbert Oliveira, PhD, Bianca Lisboa, PhD, Ricardo Helman, MD PhD, Iracema Esteves, MD, Breno Gusmao, Nelson Hamerschlak, MD PhD, Paulo Vidal Campregher, MD PhD

Blood (2017) 130 (Supplement 1): 2934.

https://doi.org/10.1182/blood.V130.Suppl_1.2934.2934

Published: 2017

NARROW

Impact of Daratumumab-Containing Induction Therapy on Stem Cell Mobilization in Multiple Myeloma: A Retrospective, Single-Center Analysis

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Autologous Stem Cell Transplantation (ASCT) for Light Chain (AL) Amyloidosis: A Single-Center Report

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Real World Evidence- the Proportion of Myeloma Patients' Death Due to Early Progression

Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Analysis of Patterns of Co-Occurrence and Mutual Exclusivity of Gene Mutations in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only